25-Aug-2010
Year Ended 30 June 2010 Results Announcement
25-Aug-2010
Preliminary Final Report
10-Aug-2010
Appendix 3B
10-Aug-2010
Appendix 3B
29-Jul-2010
Appendix 4C - quarterly
28-Jul-2010
CEO Investor Presentation
15-Jul-2010
Alchemia and Dr Reddys expand marketing collaboration
12-Jul-2010
Alchemia Phase III trial adopted by the UK NCRN
7-Jul-2010
Competitor files DMF for Fondaparinux Sodium
4-May-2010
Alchemia Receives $1m Grant for Novel Pain Killer Project